Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error. Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Prostate
  • Prostatic Neoplasms

abstract

  • Our results have important implications for cancer biomarker discovery in general and development of a sampling error-resistant clinical biopsy test for prediction of prostate cancer aggressiveness.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4453845

Digital Object Identifier (DOI)

  • 10.1038/bjc.2014.396

PubMed ID

  • 25032733

Additional Document Info

start page

  • 1201

end page

  • 12

volume

  • 111

number

  • 6